Blog

We've all heard the buzzwords-"bio-identical," "natural," "optimized."  But when you're actually in the thick of the menopause transition, you don't need a marketing pitch; you need a roadmap based on clinical fact.  I recently went down the rabbit hole of Dr. Peter Attia's latest deep dive into Hormone Replacement Therapy, and while the science is fascinating, there is a lot of noise out there that can lead to unnecessary cost and avoidable risks.  

1. Diagnosis: Symptoms Over Expensive Labs

While Peter Attia focuses on Follicle Stimulating Hormone (FSH) as a marker (specifically looking for levels hitting >20-25 IU/L), it is crucial to understand that perimenopause is primarily a clinical diagnosis. 

In many cases, expensive lab testing (meaning you pay for this via a provider who does NOT have access to direct billing, government funded lab work), or lab testing even when covered by the medical services plan, is unnecessary. 

Because hormones fluctuate wildly throughout the day and month, a single blood draw can be misleading. If you are experiencing hot flashes, night sweats, or irregular cycles, those clinical signs are the most reliable indicators to begin a conversation with your healthcare provider. 

2. The "Bio-Identical" Myth vs. Reality

"Bio-identical" has become a major wellness catchphrase, but it’s important to look past the marketing. In most cases, it simply means the hormones are plant-derived. While these are popular, they aren't inherently "better" or safer than other options.

In fact, synthetic hormones (progestins) continue to be a safe, effective, and well-studied way to treat menopausal symptoms. This is especially true for women who are sensitive to natural progesterone, which can sometimes cause moodiness or bloating. The best formulation is the one that works for your specific body, not the one with the trendiest label.

Note: If you have a uterus and use estrogen, some form of progestogen (synthetic or natural) is non-negotiable to protect the uterine lining.

3. Why Regulation Matters (The Risk of Compounding)

When it comes to sourcing treatment, stick to Health Canada (aka "FDA") approved and regulated formulations. I do not endorse compounded estrogen or progesterone.
Because compounded hormones are not regulated or Health Canada-approved, they pose inherent risks. Without the strict oversight applied to mass-produced pharmaceuticals, doses are not predictable. This lack of standardization means you cannot be certain of the potency or consistency of what you are putting in your body.

4. It’s Not Just About Estrogen

We usually focus on Estrogen, but the "missing link" for many women is Testosterone. It isn't just for men; it is a major driver for libido, maintaining muscle mass, and clearing the mental "fog" that often hits in your 40s and 50s. 

5. The "Window of Opportunity"

Timing is everything. Research suggests that starting HRT near the onset of menopause offers the best protection for your heart, bones, and brain. If you wait 10–20 years after the transition to start, the risk-reward profile changes, making early intervention key.

This is also referred to the "timing hypothesis" particularly in relation to the WHI study (read my earlier blog here). Those who started hormone therapy outside this window of opportunity exprienced higher risk for negative outcomes. BUT... after one year of therapy, these risks diminished to the same level of risk as those who started HT earlier. 

By focusing on the "window of opportunity" for early intervention and addressing often-overlooked factors like testosterone for mental clarity and muscle mass, we can navigate this transition with safety and predictability instead of falling for the noise of marketing lingo and profit-driven (over evidence based) practices.

-Dr. C Remi DNP, MN-ANP, Dip ACLM, CCRN, CCN
Family Nurse Practitioner